Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDEA: Prevention of Delayed CINV
NCT02135510Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2013
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metoclopramide, palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Amsterdam University Medical Center. Started Jun 2013; status: completed.
02
Drugs
metoclopramidepalonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02135510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135510.